Randal Chatman
Chief Executive Officer at ThermoTek, Inc.
Profile
Before joining ThermoTek Corporation as Chief Executive Officer, Randal C.
(Randy) Chatman served as Vice President of Strategic Contracting, Pricing, National Accounts, Reimbursement & Market Access at Wright Medical Group (NASDAQ: WMGI, acquired by Stryker Corporation, NYSE: SYK).
Mr. Chatman has over twenty-five years of medical device experience as an accomplished senior executive with Stryker Corporation, Medtronic and Johnson & Johnson.
He served in key leadership roles in Sales, Corporate Accounts, Marketing, Pricing, Business Development, Reimbursement and Market Access.
Randy is a graduate of the University of Oklahoma with a B.A.
in Business Communications, and he earned an Associate Fellowship from the University of Pennsylvania Wharton School of Business in The Leonard Davis Institute of Health Economics.
Randal Chatman active positions
| Companies | Position | Start |
|---|---|---|
Havencrest Capital Management LLC
 Havencrest Capital Management LLC Investment ManagersFinance Havencrest Capital Management LLC (Havencrest Capital) is a private equity firm founded in 2017 by Christopher W. Kersey. The firm is headquartered in Dallas, Texas. | Private Equity Investor | - |
ThermoTek, Inc.
 ThermoTek, Inc. Medical SpecialtiesHealth Technology ThermoTek, Inc. provides medical, aesthetic and thermal management device. It provides a broad range of temperature management solutions to the medical and industrial end markets, specifically cold compression devices used in post-orthopedic surgery rehabilitation and cooling units used in industrial applications. The company was founded by Tony Quisenberry in 1993 and is headquartered in Flower Mound, TX. | Chief Executive Officer | 28/02/2021 |
Former positions of Randal Chatman
| Companies | Position | End |
|---|---|---|
ev3, Inc.
 ev3, Inc. Medical SpecialtiesHealth Technology ev3, Inc. is a provider for specialists treating a range of vascular diseases and disorders. ev3 is committed to the peripheral vascular and neurovascular markets offering a portfolio of treatment options, including interventional technologies used such as plaque excision systems, PTA balloons, stents, embolic protection, thrombectomy, embolization coils, liquid embolics, occlusion balloons and procedural support. | Director/Board Member | - |
Biomerix Corp.
 Biomerix Corp. Chemicals: SpecialtyProcess Industries Biomerix Corp. engages in the development and manufacture of porous polyurethane materials. The company was founded by Steven I. Hochberg, Peter David Constantino, and Andrew Massik in 2001 and is headquartered in New York, NY. | Sales & Marketing | - |
Training of Randal Chatman
| University of Oklahoma | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Biomerix Corp.
Biomerix Corp. Chemicals: SpecialtyProcess Industries Biomerix Corp. engages in the development and manufacture of porous polyurethane materials. The company was founded by Steven I. Hochberg, Peter David Constantino, and Andrew Massik in 2001 and is headquartered in New York, NY. | Process Industries |
Havencrest Capital Management LLC
Havencrest Capital Management LLC Investment ManagersFinance Havencrest Capital Management LLC (Havencrest Capital) is a private equity firm founded in 2017 by Christopher W. Kersey. The firm is headquartered in Dallas, Texas. | Finance |
ThermoTek, Inc.
ThermoTek, Inc. Medical SpecialtiesHealth Technology ThermoTek, Inc. provides medical, aesthetic and thermal management device. It provides a broad range of temperature management solutions to the medical and industrial end markets, specifically cold compression devices used in post-orthopedic surgery rehabilitation and cooling units used in industrial applications. The company was founded by Tony Quisenberry in 1993 and is headquartered in Flower Mound, TX. | Health Technology |
ev3, Inc.
ev3, Inc. Medical SpecialtiesHealth Technology ev3, Inc. is a provider for specialists treating a range of vascular diseases and disorders. ev3 is committed to the peripheral vascular and neurovascular markets offering a portfolio of treatment options, including interventional technologies used such as plaque excision systems, PTA balloons, stents, embolic protection, thrombectomy, embolization coils, liquid embolics, occlusion balloons and procedural support. | Health Technology |
- Stock Market
- Insiders
- Randal Chatman
